CARLSBAD, Calif.--(BUSINESS WIRE)--Helixis, Inc., an early-stage diagnostics company focused on the development of low-cost, fast and accurate molecular diagnostic products, today announced the formal launch of the company’s operations. Helixis’ $10M Series A funding has been led by venture capitalists Jim Blair of Domain Associates and Sharon Stevenson of Okapi Venture Capital.
